In this episode of the podcast, Joe sits down with Co-Founder and CEO of Numinus, Payton Nyquvest, this time for a full episode (you may remember that he had a brief segment in Solidarity Friday #86).
Nyquvest tells the story of how ayahuasca became the cure for his chronic pain, and discusses pain in general and how we deal with it: how people so often fall into a box where their diagnosis becomes their identity, and how so much of healthcare is about alleviating the symptoms but never getting to the root cause.
He talks about how Numinus came about; how Health Canada’s Special Access Program could be huge towards more legalization; his concerns with the rush to ketamine and virtual therapy; patents and Compass Pathways; the importance of a safe container and community; and the need for a shift in how we view psychedelics and self work, from something we view as a last ditch resort to something we treat more as regular preventative tune-ups or check-ins.
Numinus is working with MAPS in their Phase 3 MDMA for PTSD study, and due to a license amendment by Health Canada that now allows them to produce a product from natural fungi, they have just produced what may be the first legal psilocybin mushroom since the 1970s.
Notable Quotes
“[I] saw this possibility [that] someone, through shifting their mental health and mental state, could greatly become a better version of themselves. And so, in my mid-to-late teens, became very, very passionate about mental health and my own mental health, and the intersection of mental health [and] physical health, and the recognition that you can’t compartmentalize the two. They’re all part of the same thing.”
“If you look at AA for example, there’s not a city on the planet I think that you could go to where you don’t find an AA community. And while certainly all these communities have their strengths and weaknesses, it really shows that with a really, really strong community, you can really help facilitate a lot of healing. …While the psychedelic experience is important, the integration and ongoing support and community is, I would argue, as important or more so.”
“I encourage everybody to read the results from the MAPS Phase 3 work, which is probably, I would argue, the most astounding clinical data we have on psychedelics for treatment-resistant PTSD, which, for anybody who doesn’t know; treatment-resistant PTSD is– this is a population of people who have tried every other treatment and have failed. Over 80% of people who went through the MDMA protocol saw a significant reduction in their symptoms and 67% actually no longer met the PTSD criteria after three treatments. That’s a cure for treatment-resistant PTSD, which is just an astounding thing to be able to say.”
Links
The End of Alzheimer’s: The First Program to Prevent and Reverse Cognitive Decline, by Dale Bredesen
”Eyes on Oregon” YouTube Playlist
Psychedelicmedicinecoalition.org
About Payton Nyquvest
Payton Nyquvest is the Founder, Chair & Chief Executive Officer of Numinus, a company that empowers people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. He has a deep understanding of the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple therapy modalities. Additionally, Payton has deep business leadership experience, particularly in the finance sector, and is a recognized innovator and visionary in mental health care. At Numinus, he guides teams leading strategy, innovation, research and clinic network expansion, and supports the marketing and capital markets functions. He is responsible for raising more than $70 million for Numinus in the past year, and is quoted widely in media such as CTV, Forbes and the New York Times. In addition, he brings more than 15 years working in finance, investment and retail banking with some of Canada’s leading independent investment firms, including Jordan Capital Markets, Canaccord Financial and Mackie Research Capital. In these and other roles, he has raised more than $100 million for a variety of small cap companies.
Instagram: @paytonnyquvest / @numinusinc
Twitter: @paytonnyquvest / @NuminusWellness
Linkedin: PaytonNyquvest / NuminusWellness
Facebook: NuminusWellness
Support the show!
- Patreon
- Leave us a review on Facebook or iTunes
- Share us with your friends
- Join our Facebook group – Psychedelics Today group – Find the others and create community.
Navigating Psychedelics
Annie Mithoefer, B.S.N., is a Registered Nurse living in Asheville, North Carolina, where she is now focused primarily on training and supervising therapists conducting MAPS-sponsored clinical trials, as well as continuing to conduct some MAPS research sessions in Charleston, South Carolina. Between 2004 and 2018, she and her husband, Michael Mithoefer, M.D., completed two of the six MAPS-sponsored Phase II clinical trials testing MDMA-assisted therapy for PTSD, as well a study providing MDMA-assisted sessions for therapists who have completed the MAPS Therapist Training, and a pilot study treating couples with MDMA-assisted therapy combined with Cognitive Behavioral Conjoint Therapy. Annie is a Grof-certified holotropic breathwork practitioner, is trained in Hakomi Therapy, and has 25 years experience working with trauma patients, with an emphasis on experiential approaches to therapy.
Michael Mithoefer, M.D., is a psychiatrist living in Asheville, NC, with a research office in Charleston, SC. He is now a Senior Medical Director at MAPS Public Benefit Corporation (MPBC). He is a Grof-certified holotropic breathwork facilitator, is trained in EMDR and Internal Family Systems Therapy, and has nearly 30 years of experience treating trauma patients. Before going into psychiatry in 1991, he practiced emergency medicine for ten years. He has been board certified in Psychiatry, Emergency Medicine, and Internal Medicine, and is a Fellow of the American Psychiatric Association, and Affiliate Assistant Professor Department of Psychiatry and Behavioral Sciences Medical University of South Carolina.
Founder and Editor of Psilocybin Alpha, an online resource and weekly newsletter covering the psychedelics space with a focus on drug development efforts.
Joe Tafur, MD, is a Colombian-American family physician originally from Phoenix, Arizona. After completing his family medicine training at UCLA, Dr. Tafur spent two years in academic research at the UCSD Department of Psychiatry in a lab focused on mind-body medicine. After his research fellowship, over a period of six years, he lived and worked in the Peruvian Amazon at the traditional healing center Nihue Rao Centro Espiritual. There he worked closely with master Shipibo healer Ricardo Amaringo and trained in ayahuasca curanderismo. In his book, 
Jonathan Sabbagh the co-founder and CEO of 
Greg McKee serves as Chairman and Chief Executive Officer of 
Zac Kamenetz is a rabbi, community leader, and aspiring psychedelic-assisted chaplain based in Berkeley, CA. He holds an MA in Biblical literature and languages from UC Berkeley and the Graduate Theological Union and received rabbinic ordination in 2012. As the founder and CEO of 
Hunt Priest is an Episcopal priest and the founding Executive Director of 
Dr. Oliver Grundmann 
Danny Peterson is a founding member and the Executive Director of the Association of Entheogenic Practitioners (
Joe Zap spent over two years living nomadically, traveling the Western U.S. and working remotely in a camper van with his wife, Ashleigh, before relocating to Boulder, Colorado in the middle of 2020. His full-time livelihood is Apple technology consulting, having owned and run a technology consultancy since 2004 while being an Advisory Council Member of the Apple Consultants Network. In 2013, Joe founded 
Kevin W is a Co- host of Entheogen show, avid Burner and devout believer in the science of Psychedelics.
Ayize Jama-Everett (b. NYC 1974) has been in various relationships with plants, substances, and communities since his birth. Born into the Black Power movement’s conflicts, Ayize comes from the lineage of the Lincoln Detox project, a community organization in Harlem, New York, that taught the formerly incarcerated to use acupuncture to help with heroin withdrawal. At sixteen, he traveled to Morocco and was taken in by the Gnawa and was privileged to join their rituals. Ayize served as the director of Outpatient services for Thunder Road Adolescent Treatment center for three years before joining Catholic Charities of Treasure Island as the substance use and mental health services manager. He’s worked in both abstinence and harm reduction modalities. He also served as a high school therapist for over a decade.
Courtney Watson is a Licensed Marriage and Family Therapist and AASECT Certified Sex therapist. She is the owner of Doorway Therapeutic Services, a group therapy practice in Oakland, CA focused on addressing the mental health needs of Black, Indigenous & People of Color, Queer folks, Trans, Gender Non-conforming, Non binary and Two Spirit individuals. Courtney has followed the direction of her ancestors to incorporate psychedelic assisted therapy into her offerings for folks with multiple marginalized identities and stresses the importance of BIPOC and Queer providers offering these services. Courtney has received training from the Center for Psychedelic Therapies and Research at CIIS, MAPS and Polaris Insight Center to provide psychedelic-assisted therapy with a variety of medicines.
Leticia Brown (she/her/hers) is a Licensed Marriage and Family Therapist and Black queer femme whose practice engages various healing modalities at the intersections of harm reduction, sexuality and social justice. She prioritizes work with BIPOC & QTNBIPOC communities through a liberatory lens that values communual interdependence and affirms the inner healer we all hold within. Constantly exploring ways to decolonize her relationship to healing, she incorporates intergenerational exploration, spirituality, ritual, the use of the body, and reconnection to intuition in her practice, and sees her role as co-creator with those she walks beside on their healing journeys.
Kufikiri Imara was born and raised on Huichin territory of the Ohlone people (Oakland, California). With parents that were involved in the Civil Rights and Black Power movements of the 1960s and 1970s, he grew up in a family and community that strongly emphasized cultural awareness and social responsibility. He volunteered with Green Earth Poets Society in NYC, bringing poetry to incarcerated African-American youth. He was an early member of the Entheogen Integration Circle in NYC, supporting marginalized communities. He is a friend of Sacred Garden Community as a facilitator. A former member of the Decriminalize Nature Oakland grassroots collective, he went on to head the DNO committee on Outreach, Education, Access, & Integration. He lent his voice to the Horizons Media documentary film “Covid-19, Black Lives, & Psychedelics.” He also facilitates a BIPOC Entheogen Integration Circle with the San Francisco Psychedelic Society. Kufikiri Imara is a voice championing the important issues of access, education, and inclusion within the larger psychedelic community.
Ryan Zurrer, 
Dr. Ben Sessa’s joint interests in psychotherapy, pharmacology, and trauma have led him towards researching the subject of drug-assisted psychotherapy using psychedelic adjuncts. In the last 15 years, he has been part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. He is the author of psychedelic medical exploration books; 
Josh Bartch is Director, Chief Executive Officer, and Chairman of Mydecine Innovations Group (MIG). Mr. Bartch’s entrepreneurial career took off in 2009 when he co-founded AudioTranscriptionist.com and founded the Denver-based dispensary, 
Micah is the founder of 
With Over 15 years founding, scaling, and operating innovative businesses across several industries, Kelsey Ramsden has built multiple eight-figure companies from the ground up. She is an experienced leader and acclaimed entrepreneur, twice recognized as Canada’s Top Female Entrepreneur of the Year. After serving as 
James Fadiman, PhD., has been researching psychedelics since 1961 and the effect of microdosing since 2010. His most recent books are The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys and Your Symphony of Selves: Discover and Understand More of Who We Are (with Jordan Gruber). He is working on a new book about microdosing and wants to hear remarkable microdosing stories: 
Payton Nyquvest is the Co-founder, Chair & Chief Executive Officer of 
Juan Pablo Cappello is a passionate entrepreneur who believes in the power of technology and innovation to address humanity’s biggest challenges — mental wellness being one of them. In his home country of Chile, Juan Pablo has seen both the trauma caused by years of a military dictatorship and the power of psychedelic therapies to heal that trauma. As 
Ahmad Doroudian, Ph.D. is the Chief Executive Officer & Director 
Dr. Abid Nazeer is the Chief Medical Officer for 
Erica Rex writes about science, environment, mental health, climate, and the forces shaping all of them. She’s written for The New York Times, Scientific American, The Times (UK), and is the recipient of a National Magazine Award. She was a subject in one of the first clinical trials using psilocybin to treat cancer related depression in 2012. Her book-in-progress traces the story of psychedelics through the lens of her quest to heal from childhood trauma. Ms Rex’s unique perspective shows how psychedelic medicine provides a pathway out of trauma, a light at the end of a very long tunnel.
Jeremy Narby, PhD, is co-author of 
Rachel Yehuda is an Endowed Professor of Psychiatry and Neuroscience of PTSD and Vice Chair for Veteran Affairs in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, where she directs the Center for Psychedelic Psychotherapy and Trauma Research and the Traumatic Stress Studies Division. She is also Director of Mental Health at the James J. Peters VA Medical Center in the Bronx. She is the recipient of numerous federal grants and awards, has authored several hundred peer-reviewed scientific papers, and is a member of the National Academy of Medicine. Dr. Yehuda’s work has focused primarily on the neuroscience and treatment of trauma and PTSD. 
Patrick Moher is an industrious entrepreneur working in psychedelics and cannabis, currently the CEO at Microdose Psychedelic Insights. As a passionate and unapologetic environmentalist, his relentless work ethic has directly translated to previous success in his photography career, as well as founding Ethical Image, co-finding Alan Aldous Communications, Goodwood Accessories, UCannAcademy & and becoming a partner at ADCANN. Patrick is focused on helping combine creativity, CSR, and sustainable profitability for companies. He has a dynamic ability to unite individuals across social and corporate spectrums to create unique business solutions. His dedication to community service has seen him actively collaborate with many volunteer organizations, photograph hundreds of events/portraits/weddings, & sponsor the planting of over 20,000 trees (and counting).
Rebecca Kronman, LCSW, is a licensed therapist, mother of two and founder of Plant Parenthood, a digital and in-person community of parents who use psychedelics. She is a psychotherapist with a private practice in Brooklyn, New York, where she offers ketamine-assisted psychotherapy and works with clients to prepare for and integrate after psychedelic experiences. She is also a writer, and wrote “
Liam Farquhar is a legal psychedelic guide and integration specialist, working between London and Amsterdam. He also does men’s group work and therapeutic work. He uses a ‘7 Lens’ approach that he developed as the foundation for all his services, combining: Internal Family Systems; Grofian (based on the work of Stanislav Grof); Jungian (based on the work of Carl Jung); Mindfulness; Scientific; Shamanic; and Trauma/Somatic. He is also a past Navigating Psychedelics graduate. 
Jerry B. Brown, Ph.D., is an anthropologist, author, and ethnomycologist. He is a Founding Professor of Anthropology at Florida International University (FIU) in Miami, where he teaches an online course on “Psychedelics and Culture.” He also co-created the “Psychedelics: Past, Present, and Future” course for us. Professor Brown teaches and writes on psychedelics and religion as well as on psychedelic therapy. He is coauthor (with Julie Brown, LMHC, an integrative psychotherapist and also his wife) of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity, 2016.
Jessica is a Medical Anthropologist working at Maya Public Benefit Corporation (PBC) as a Research Manager. As the former Executive Director of the Montreal Psychedelic Society, Jessica is passionate about bridging the non-for-profit and for profit world of psychedelic initiatives. With a particular interest in the intermingling of 12-step methods of managing addiction and psychedelic-assisted therapy, Jessica is concerned with ensuring that psychedelic practices are carefully and ethically integrated into modern Western society and culture. Email her at: 
Gibrán Rivera is a teacher, coach, guide, and Master Facilitator. He is devoted to the development of leaders and leadership networks. He works to help figure out how to thrive in times of VUCA (Volatility, Uncertainty, Complexity, Ambiguity). Gibrán is the originator of the Evolutionary Leadership Workshop, host of the Better Men Project, and one of the teachers of What Should White People Do? His work brings close attention to dynamics of power, equity, and inclusion. He has designed and facilitated the coming together of some of the most prestigious fellowships in the country, and he specializes in transformational offsite retreats. His work is based on the understanding that our next evolutionary leap depends on trust and the currency of love, and he is devoting his life to defining better ways of being together in this world.
Michelle Janikian is a journalist and the author of 
Carlene MacMillan, M.D. is the co-founder/CEO of Brooklyn Minds. She is a Harvard-trained adult and child psychiatrist who pioneers team-based and tech-enabled mental health care that helps individuals with complex psychiatric concerns live meaningful lives. She collaborates with stakeholders to build novel value-based (as opposed to volume-based) care models. Dr.MacMillan is also known for her role as the co-host of New Frontiers, an award-winning show on Clubhouse where mental health experts weigh in on aspects of our culture. She is an internationally recognized leader in Mentalization Based Treatment, collaborating with leaders at the Anna Freud National Centre for Children and Families. She is on the Clinical Advisory board of Osmind and a member of the Ketamine Taskforce for Access to Safe Care and Insurance Coverage. She is on the Clinical TMS Society Insurance Committee and is the co-Chair of the American Academy of Child and Adolescent Psychiatry Consumer Issues Committee.
Tiago Reis Marques is a senior fellow at Imperial College, a lecturer at the Institute of Psychiatry, King’s College London and a psychiatrist at the prestigious Maudsley Hospital. The Maudsley Hospital and the Institute of Psychiatry constitute the largest psychiatry center in Europe and ranks among the 3 best in the world. During his research career, he has received numerous prestigious awards, including the Young Investigator Award from the Brain and Behavior Research Foundation, the Research Award from the Royal Society of Medicine’s psychiatry section and the Young Investigator Award of the International Congress on Schizophrenia Research. He is also a co-funder and CEO of Pasithea, a biotech company developing new drugs for the treatment of psychiatric and neurological disorders.
Benjamin Mudge has a background in music, art and political activism, and is now a PhD candidate in the Psychiatry Department at Flinders University, as well as Director of Bipolar Disorder CIC. He taught himself the science of bipolar disorder, while working at Neuroscience laboratories and GlaxoSmithKline, to be able to manage his own personal experience of manic depression. After psychiatrists prescribed him 17 different pharmaceuticals (all of which were problematic), he gave up on pharmaceutical psychiatry and decided to find his own solution to living with manic depression. He has been managing his bipolar disorder with ayahuasca for 14 years – without any need of pharmaceuticals – and was awarded a PhD scholarship to research whether his personal protocol could assist other bipolar people. His future vision is to make ayahuasca ceremonies available to bipolar people as an alternative treatment to pharmaceutical drugs.
Dr. Devon Christie, MD, is a clinical instructor with the UBC Department of Medicine and has a focused practice in chronic pain. She is a Registered Counsellor emphasizing Relational Somatic Therapy for trauma, and a certified Mindfulness Based Stress Reduction teacher (UCSD) and Interpersonal Mindfulness teacher (UMass). She is trained to deliver both MDMA-assisted therapy for PTSD (MAPS USA) and ketamine-assisted psychotherapy. She is passionate about educating future psychedelic therapists on trauma-informed, relational somatic skills and is co-founder of the Psychedelic Somatic Psychotherapy training program. She also teaches for the California Institute of Integral Studies (CIIS) Certificate Program in Psychedelic Therapy and Research, the Integrative Psychiatry Institute Certificate Program in Psychedelic Assisted Therapy, and the ONCA Foundation Psychedelic Therapy program. She is currently Principal Investigator and study therapist for a Canadian MAPS-sponsored open-label compassionate access study investigating MDMA-assisted therapy for PTSD, co-investigator on a study investigating MDMA-assisted therapy for fibromyalgia, and is the Medical and Therapeutic Services Director with Numinus Wellness Inc.
Manesh is a Ph.D. candidate in Neuroscience at McGill University and has been lead or co-author on over a dozen scientific publications and book chapters on topics including psychedelics, meditation, mind-wandering, and the default-mode network. His Ph.D. dissertation focuses on the default-mode network and he is also conducting research on the brain mechanisms underlying LSD, psilocybin, and DMT in collaboration with Dr. Robin Carhart-Harris and others from the Imperial College London Center for Psychedelic Research. In his free time, he also runs a YouTube channel, 
Ismail L. Ali is Policy & Advocacy Counsel for MAPS, where he advocates to eliminate barriers to psychedelic therapy and research, develops and implements legal and policy strategy, and coordinates support for clinical research in Latin America. Ismail is licensed to practice law in the state of California and also serves as Vice-Chair of the Students for Sensible Drug Policy Board of Directors. Ismail earned his J.D. at the University of California, Berkeley School of Law in 2016, after receiving his Bachelor’s in Philosophy from California State University, Fresno, in 2012, where he also studied writing and Spanish-language literature. As a law student, Ismail served as co-lead of Berkeley Law’s chapter of Students for Sensible Drug Policy and worked for the ACLU of Northern California’s Criminal Justice and Drug Policy Project, and the International Human Rights Law Clinic at Berkeley Law. To first support his work at MAPS, Ismail received Berkeley Law’s Public Interest Fellowship. Ismail believes that psychedelic consciousness is a crucial piece of challenging oppression in all of its forms, and that legal access to psychedelics is an essential part of a progressive drug policy paradigm. He hopes to help develop and advocate for just, equitable, and creative alternatives to the failed war on drugs.
Robin Divine is a writer, psychedelic advocate, and the creator of 
Matthew D. Segall, PhD, is assistant professor in the Philosophy, Cosmology, and Consciousness program at California Institute of Integral Studies in San Francisco, where he teaches courses primarily on German Idealism and Alfred North Whitehead’s process philosophy. He is the author of Physics of the World-Soul: Whitehead’s Adventure in Cosmology (2021) and has published journal articles and book chapters on a wide range of topics including panpsychist metaphysics, media theory, the philosophy of biology, the evolution of religion, and psychedelics. He blogs regularly at 
asmine Virdi is a freelance writer in the psychedelic space. Since 2018, she has been working for the independent publishing company 
Daniel Moler 
Sean Hinton is a psychologist counseling individuals in their personal and spiritual growth, an executive consultant to business leaders, and a lecturer and graduate school instructor in psychology. 
Originally from the Pacific Northwest and raised in a little logging town on the Columbia River, Joel Lambert grew up performing on stage and in commercials before selling all he had and running off to join the armed forces, where he served as a Navy SEAL for ten years, earning distinction and experiencing combat in places like Kosovo and Afghanistan. Returning home decorated and serving as a lead Instructor at BUD/S, the screening and selection school for men aspiring to join the elite Navy SEALs, he was drawn back into the world of film and television.
Husband-and-wife team, Jonas Di Gregorio and Kristina Soriano, established the 
Hadas Alterman is an Israeli-American attorney, born in Jerusalem and raised in the San Francisco Bay Area. She has a J.D. from Berkeley Law and a B.A. in Community Studies/Agriculture & Social Justice from the University of California at Santa Cruz. Prior to founding Plant Medicine Law Group, she worked with a leading cannabis law firm in San Francisco. Hadas was the Policy Director of NYMHA, an organization that she co-founded that successfully lobbied for the introduction of a New York bill to decriminalize psilocybin by statute, and is a Board Member of the Psychedelic Bar Association. She also serves on the Equity Subcommittee of the Oregon Psilocybin Advisory Board.
Serena Wu is a Chinese-American lawyer, born in Hainan and raised in Los Angeles. She has a J.D. from Harvard University Law School and a B.A. in Media Studies from University of California, Berkeley. Serena began her legal career at Davis Polk & Wardwell LLP in New York City as a litigation associate, and is deeply committed to increasing equitable access to alternative healing, including psychedelic plant medicines. She is the founder of @womeninpsychedelics, an Instagram account that showcases the contributions, voices, and experiences of women in the psychedelics space, and Asian Psychedelics Society (“APS”), a group dedicated to discussions about psychedelics and mental health in the AAPI community. 
Adriana Kertzer is a Brazilian-American attorney, born and raised in São Paulo. Adriana has a J.D. from the Georgetown University Law Center, a B.A. from Brown University in Judaic Studies and International Relations, and an M.A. from Parsons The New School for Design. She began her legal career as a corporate associate on Simpson Thacher & Bartlett’s Latin American capital markets team. She was Senior Advisor to the Senior Deputy Chairman at the National Endowment for the Arts under President Obama, is on the board of Doctors for Cannabis Regulation, and is the author of the book 
Pierre Bouchard is a Licensed Professional Counselor with a private practice in Boulder and Denver, CO. He specializes in blending somatics, embodiment, attachment theory, and trauma therapy with ketamine-assisted psychotherapy. A graduate of Naropa University (in Contemplative Psychotherapy), he has trained in several somatic psychotherapy modalities, most recently the Hakomi Method under Melissa Grace, and currently, in Ido Portal’s movement system at Boulder Movement Collective. He has maintained a meditation practice for 19 years, is working on opening a ketamine clinic, and in his spare time, works as a vinyl DJ.
Julian Vayne is widely recognized as one of Britain’s leading occultists. He is an independent scholar and author with over three decades of experience within esoteric culture: from Druidry to Chaos Magic, from indigenous Shamanism through to Freemasonry and Witchcraft. He is a senior member of the Magical Pact of the Illuminates of Thanateros, a co-organizer of the psychedelic conference, Breaking Convention, a Trustee of The Psychedelic Museum Project, a founding member of the post-prohibition think-tank, Transform, sits on the academic board of The Journal of Psychedelic Studies, and has been a visiting lecturer at several British universities. He is an advocate of post-prohibition culture and supporter of psychedelic prisoners through the Scales project. Julian facilitates psychedelic ceremony, as well as providing one-to-one psychedelic integration sessions and support. He is the author of Getting Higher: The Manual of Psychedelic Ceremony, and since 2011, he has been sharing his work through his blog, The Blog of Baphomet.
About Benjamin Mudge
Franklin King IV, MD, is the director of training and education at the Mass General Center for the Neuroscience of Psychedelics and a clinical instructor at Harvard Medical School. His primary clinical and research interest is in the utilization of psychedelic-assisted psychotherapy to treat a variety of chronic psychiatric conditions, including depression and anxiety disorders, and in strategies to optimize these interventions for different patient populations. In addition, Dr. King teaches and supervises residents and fellows at Mass General, and practices clinically as a staff psychiatrist at the Center for Anxiety and Traumatic Stress Disorders as well as on the Acute Psychiatry Service in the Emergency Department.
Gary Laderman, Goodrich C. White Professor of American Religious History and Cultures, is the author of the new book, Don’t Think About Death: A Memoir on Mortality (Deeds Publishing, 2020), and hosts the podcast, Sacrilegious.
About Nick Meyers and 
About Tim Cools
About Ralph Blumenthal
About Richie Ogulnick
About Kile Ortigo
About Dena Justice
About the Entheo Society of Washington
About Christopher Solomon
About JR Rahn